Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taiji water plus benzbromarone in gout patients with hyperuricemia
ChiCTR1800020227Phase 4Recruiting
- Sponsor
- The Affiliated Hospital of Qingdao University
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of benzbromarone in gout and hyperuricemia (3 arms), sponsored by The Affiliated Hospital of Qingdao University. Primary endpoints: Urine pH, Serum uric acid and 1 more. Started Dec 2018; status: recruiting.
02
Drugs
benzbromarone
03
Conditions
gouthyperuricemia
Beyond the preview
Go deeper on ChiCTR1800020227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800020227.